Eon Mini - 3788 (IPG), Eon Mini system is indicated as an aid in the management of chronic in...

FDA Device Recall #Z-1836-2013 — Class II — July 26, 2012

Recall Summary

Recall Number Z-1836-2013
Classification Class II — Moderate risk
Date Initiated July 26, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm St. Jude Medical
Location Plano, TX
Product Type Devices
Quantity 34,617

Product Description

Eon Mini - 3788 (IPG), Eon Mini system is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs including unilateral or bilateral pain associated with the following: failed back, surgery syndrome, intractable low back and leg pain.

Reason for Recall

As part of St. Jude Medical's routine tracking and product monitoring, they have received a total of 214 reports, out of 34,617 Eon Mini IPGs, that lost the ability to communicate or recharge due to an inner battery weld issue resulting in loss of pain relief and subsequent explant. Explant surgery, as with any surgery, presents a risk to patient health. Adverse events associated with an unplanne

Distribution Pattern

Worldwide Distribution--USA (nationwide) including Puerto Rico and the countries of Argentina, Australia, Austria, Belgium, Brazil, canada, Colombia, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, India, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Saudi, South Africa, Spain, Sweden, Switzerland, Turkey and United Kingdom.

Lot / Code Information

Multiple lots recalled are the ones with supplier's inner battery lots of 326-508

Other Recalls from St. Jude Medical

Recall # Classification Product Date
Z-1427-2025 Class II CardioMEMS Heart Failure (HF) System that consi... Feb 3, 2025
Z-0987-2025 Class II Merlin.net Patient Care Network (PCN) Heart Fai... Nov 6, 2024
Z-0988-2025 Class II CARDIOMEMS HF PRESSURE MEASUREMENT SYSTEM Card... Oct 5, 2024
Z-0989-2025 Class II CARDIOMEMS HF PRESSURE MEASUREMENT SYSTEM Card... Oct 5, 2024
Z-2348-2024 Class II St. Jude Medical Agilis NxT Steerable Introduce... Apr 30, 2024

Frequently Asked Questions

Contact your physician immediately if you use an electrical device or implant affected by this recall. For external devices (monitors, pumps), stop using the device and contact the manufacturer for a replacement. For implanted devices (pacemakers, ICDs), your cardiologist will assess whether you need device replacement surgery — the decision depends on how dependent you are on the device and the actual failure rate observed in the field. Do not attempt to repair or modify a recalled electrical medical device yourself. Monitor for any new or unusual symptoms and report them to your doctor.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.